Lara Meisner, Chief Legal Officer at Bicara Therapeutics Inc. (BCAX), sold 31,658 shares at $11.49 ($364K) on 2025-09-15, disclosed to the SEC on 2025-09-17.
Scheduled sale ($364k) by Chief Legal Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.49 | 15,829 | $182K | 50.0% |
| 2 | $11.49 | 15,829 | $182K | 50.0% |
| Total | $11.49 avg | 31,658 | $364K | 100% |
| Filing → |
| BCAX | SELL | 2025-03-18 | $2.0M | — | Filing → |
| VRDN | SELL | 2023-06-20 | $128K | — | Filing → |
| VRDN | SELL | 2023-06-06 | $314K | — | Filing → |